Pure Global

GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 10387650128

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650128 and manufactured by AALTO SCIENTIFIC, LTD.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10387650128
Registration Details
ANVISA Registration Number: 10387650128
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

CONTROL LQ GLYCOHEMOGLOBIN A1C
Risk Class II

Registration Details

10387650128

25351594331202009

02823683000102

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Dec 17, 2020

VIGENTE

09/18/2025 19:00:01